With this little drop , Solbec , the only oncology drug developer in this country to show multiple objective responses against late stage 4 cancers , and as a stand alone agent , is now the lowest price oncology drug on the board . Who said we are the clever country ??????? I could be wrong re the actual documented performance of other cancer drug companies , so please correct me if that is so . Although Solbecs was only a phase 1 trial , feel free to quote phase 1, 2 or 3 results . That is a better than 16% OBJECTIVE(>50% tumour reduction) response against any stage 4 cancer . Cheers
SBP Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
